Immediate Impact
4 from Science/Nature 79 standout
Citing Papers
GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
2024 Standout
Works of S. Hedgecock being referenced
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
2004 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| S. Hedgecock | 1548 | 1064 | 1055 | 15 | 1.8k | |
| Angel FowlerTaylor | 2125 | 1397 | 1207 | 18 | 2.3k | |
| J. Thirlwell | 1697 | 1239 | 1015 | 16 | 1.9k | |
| Andre van As | 1657 | 1233 | 670 | 20 | 1.9k | |
| H. Fox | 1758 | 1392 | 1002 | 24 | 2.0k | |
| Martin Blogg | 2220 | 1661 | 1337 | 32 | 2.4k | |
| Niroo Gupta | 2474 | 1694 | 1430 | 17 | 2.8k | |
| Steven F. Weinstein | 2270 | 1533 | 995 | 44 | 2.6k | |
| Jonathan Matz | 1375 | 1069 | 612 | 17 | 1.5k | |
| K. Britten | 1338 | 701 | 602 | 10 | 1.8k | |
| Orion P. Twentyman | 1486 | 1293 | 384 | 18 | 2.0k |
All Works
Loading papers...